IKKE and TBKI are essential components of the IRF3 signalling pathway

Nature Immunology

Volumn 4, Issue 5, 2003, Pages 491-496

  Fitzgerald, Katherine A ^a   McWhirter, Sarah M ^b   Faia, Kerrie L ^c   Rowe, Daniel C ^a   Latz, Eicke ^a   Golenbock, Douglas T ^a   Coyle, Anthony J ^c   Liao, Sha Mei ^c   Maniatis, Tom ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; PROTEIN TBK1; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; BETA INTERFERON; CELL SURFACE RECEPTOR; CHUK PROTEIN, HUMAN; DNA BINDING PROTEIN; DROSOPHILA PROTEIN; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; IRF3 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; RANTES; TBK1 PROTEIN, HUMAN; TICAM1 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BINDING; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; RNA INTERFERENCE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; IMMUNITY, NATURAL; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RANTES; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; VIRUS DISEASES;

EID: 0038393016     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni921     Document Type: Article

References (45)

1. Hiscott J. et al. Triggering the interferon response: the role of IRF-3 transcription factor. J. Interferon Cytokine Res. 19, 1-13 (1999).
2. Genin, P., Algarte, M., Roof, P., Lin, R. & Hiscott J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-κB and IFN-regulatory factor transcription factors. J. Immunol. 164, 5352-5361 (2000).
3. Barnes, B., Lubyova, B. & Pitha, P.M. On the role of IRF in host defense. J. Interferon Cytokine Res. 22, 59-71 (2002).
4. Iwamura, T. et al. Induction of IRF-3/-7 kinase and NF-κB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6, 375-388 (2001).
5. Yoneyama, M., Suhara, W. & Fujita, T. Control of IRF-3 activation by phosphorylation. J. Interferon Cytokine Res. 22, 73-76 (2002).
6. Servant, M.J. et al. Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J. Biol. Chem. 276, 355-363 (2001).
7. Servant, M.J., Grandvaux, N. & Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Bicochem. Pharmacol. 64, 985-992 (2002).
8. tenOever, B.R., Servant, M.J., Grandvaux, N., Lin, R. & Hiscott J. Recognition of the measles virus nucleo-capsid as a mechanism of IRF-3 activation. J. Virol. 76, 3659-3669 (2002).
9. Smith, E.J., Marie, I., Prakash, A., Garcia-Sastre, A. & Levy, D.E. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IκB kinase but is blocked by Vaccinia virus E3L protein. J. Biol. Chem. 276, 8951-8957 (2001).
10. Chu, W.M. et al. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11, 721-731 (1999).
11. Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663 (2000).
12. Iordanov, M.S., Wong, J., Bell, J.C. & Magun, B.E. Activation of NF-κB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol. Cell. Biol. 21, 61-72 (2001).
13. Fitzgerald, K.A. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83 (2001).
14. Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738 (2001).
15. Janssens, S. & Beyaert R. A universal role for MyD88 in TLR/IL-IR-mediated signaling. Trends Biochem. Sci. 27, 474-482 (2002).
16. Cao, Z, Henzel, W.J. & Gao, X. IRAK: a kinase associated with the interleukin-I receptor. Science 271, 1128-1131 (1996).
17. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. TICAM-I, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4, 161-167 (2003).
18. Kawai, T. et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894 (2001).
19. Toshchakov, V. et al. TLR4, but not TLR2, mediates IFN-β-induced STAT I α/β-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398 (2002).
20. Horng, T., Barton, G.M. & Medzhitov, R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841 (2001).
21. Yamamoto, M. et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324-329 (2002).
22. Yamamoto, M. et al. Cutting edge: a novel Toll/IL-I receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672 (2002).
23. Imler, J.L. & Hoffmann, J.A. Toll signaling. the TIReless quest for specificity. Nat. Immunol. 4, 105-106 (2003).
24. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109 (suppl.), S81-S96 (2002).
25. Peters, R.T, Liao, S.M. & Maniatis, T. IKKE is part of a novel PMA-inducible IκB kinase complex. Mol. Cell 5, 513-522 (2000 ).
26. Shimada, T. et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int. Immunol. 11, 1357-1362 (1999).
27. Tojima, Y. et al. NAK is an IκB kinase-activating kinase. Nature 404, 778-782 (2000).
28. Bonnard, M. et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription. EMBO J. 19, 4976-4985 (2000).
29. Peters, R.T. & Maniatis,T.A new family of IKK-related kinases may function as IκB kinase kinases. Biochim. Biophys. Acta 1471, M57-M62 (2001).
30. Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T. & Toriumi, W. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356 (1999).
31. Maniatis, T. et al. Structure and function of the interferon-β enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63, 609-620 (1998).
32. Maniatis, T. Mechanisms of human β-interferon gene regulation. Harvey Lect. 82, 71-104 (1986).
33. Wathelet, M.G. et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1, 507-518 (1998).
34. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087-1095 (1998).
35. Lin, R., Heylbroeck, C., Pitha, P.M. & Hiscott, J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18, 2986-2996 (1998).
36. Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K. & Seya, T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364-1369 (2002).
37. Muzio, M., Ni, J., Feng, P. & Dixit, V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-I signaling. Science 278, 1612-1615 (1997).
38. Janeway, C.A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002).
39. Pomerantz, J.L. & Baltimore, D. NFκ activation by a signaling complex containing TRAF2, TANK and TBKI, a novel IKK-related kinase. EMBO J. 18, 6694-6704 (1999).
40. Servant, M.J. et al. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double- stranded RNA. J. Biol. Chem. 278, 9441-9447 (2003).
41. Chariot, A. et al. Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKE, and TBKI kinases. J. Biol. Chem. 277, 37029-37036 (2002).
42. Lee, F.S., Hagler, J., Chen, Z.J. & Maniatis, T. Activation of the IκBα kinase complex by MEKKI, a kinase of the JNK pathway. Cell 88, 213-222 (1997).
43. Yang, H. et al. Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur. J. Biochem. 269, 6142-6151 (2002).
44. Latz, E. et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843 (2002).
45. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).